Janet O’Neil

473 total citations
16 papers, 269 citations indexed

About

Janet O’Neil is a scholar working on Psychiatry and Mental health, Surgery and Molecular Biology. According to data from OpenAlex, Janet O’Neil has authored 16 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Janet O’Neil's work include Gastroesophageal reflux and treatments (4 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Dementia and Cognitive Impairment Research (4 papers). Janet O’Neil is often cited by papers focused on Gastroesophageal reflux and treatments (4 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Dementia and Cognitive Impairment Research (4 papers). Janet O’Neil collaborates with scholars based in United States, Switzerland and Australia. Janet O’Neil's co-authors include María Claudia Pérez, Susan M. Buttler, Eugene Dula, Anthony Edmonds, Paul Siami, David C. Metz, Colin W. Howden, Stuart Atkinson, Lois Larsen and Reema Mody and has published in prestigious journals such as Gastroenterology, Neurology and The American Journal of Gastroenterology.

In The Last Decade

Janet O’Neil

15 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet O’Neil United States 7 119 110 86 57 35 16 269
Antonio De Rosa Italy 9 172 1.4× 229 2.1× 14 0.2× 24 0.4× 17 0.5× 15 414
Yasusuke Kimoto Japan 11 62 0.5× 10 0.1× 144 1.7× 142 2.5× 48 1.4× 23 305
Lee United States 9 46 0.4× 8 0.1× 55 0.6× 7 0.1× 27 0.8× 12 257
Seema Varma United States 9 55 0.5× 21 0.2× 122 1.4× 6 0.1× 33 0.9× 20 312
Óskar Hálfdánarson Iceland 6 67 0.6× 76 0.7× 77 0.9× 4 0.1× 22 0.6× 9 279
Steven Caras United States 11 300 2.5× 88 0.8× 66 0.8× 35 0.6× 15 0.4× 18 454
Jacob Juel Denmark 10 113 0.9× 41 0.4× 31 0.4× 4 0.1× 10 0.3× 27 282
K. Huibregtse United States 9 150 1.3× 31 0.3× 6 0.1× 33 0.6× 39 1.1× 12 308
Toshikazu Otani Japan 10 109 0.9× 7 0.1× 62 0.7× 29 0.5× 24 0.7× 33 294

Countries citing papers authored by Janet O’Neil

Since Specialization
Citations

This map shows the geographic impact of Janet O’Neil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet O’Neil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet O’Neil more than expected).

Fields of papers citing papers by Janet O’Neil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet O’Neil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet O’Neil. The network helps show where Janet O’Neil may publish in the future.

Co-authorship network of co-authors of Janet O’Neil

This figure shows the co-authorship network connecting the top 25 collaborators of Janet O’Neil. A scholar is included among the top collaborators of Janet O’Neil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet O’Neil. Janet O’Neil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Crawford, Thomas O., Basil T. Darras, John Day, et al.. (2024). Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3. Neurology. 102(5). e209151–e209151. 19 indexed citations
2.
Pokrzywinski, Robin, Hemal Shah, Nathalie Kertesz, et al.. (2023). Treatment Effects Among Patients with Type 2 and Type 3 SMA Directly Reported by Patients and Caregivers from the TOPAZ Clinical Trial (P2-8.010). Neurology. 100(17_supplement_2). 1 indexed citations
3.
Crawford, Thomas O., Basil T. Darras, John Day, et al.. (2022). Apitegromab in Spinal Muscular Atrophy (SMA): An Analysis of Multiple Efficacy Endpoints in the TOPAZ Trial (P15-5.005). Neurology. 98(18_supplement). 2 indexed citations
4.
Barrett, D, Shaun Cote, George G. Nomikos, et al.. (2021). SMA - TREATMENT. Neuromuscular Disorders. 31. S134–S134. 1 indexed citations
5.
Burns, Daniel K., Carl Chiang, Kathleen A. Welsh‐Bohmer, et al.. (2019). The TOMMORROW study: Design of an Alzheimer's disease delay‐of‐onset clinical trial. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 661–670. 30 indexed citations
6.
Romero, Heather, Andreas U. Monsch, Kathleen M. Hayden, et al.. (2018). TOMMORROW neuropsychological battery: German language validation and normative study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 314–323. 10 indexed citations
7.
8.
Budur, Kumar, Kathleen A. Welsh‐Bohmer, Daniel K. Burns, et al.. (2014). P4‐073: A PHARMACOGENETICS‐SUPPORTED CLINICAL TRIAL TO DELAY ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE USING LOW‐DOSE PIOGLITAZONE: AN UPDATE ON THE TOMORROW STUDY. Alzheimer s & Dementia. 10(4S_Part_22). 3 indexed citations
9.
Zabaneh, Raja I., et al.. (2014). Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis. Peritoneal Dialysis International. 35(4). 481–489. 3 indexed citations
10.
Welsh‐Bohmer, Kathleen A., Heather Romero, Kathleen M. Hayden, et al.. (2013). O1–06–01: Challenges in international clinical trials to delay early symptomatic Alzheimer's disease. Alzheimer s & Dementia. 9(4S_Part_3). 4 indexed citations
11.
Fishbane, Steven, Simon D. Roger, Edouard Martin, et al.. (2012). Peginesatide for Maintenance Treatment of Anemia in Hemodialysis and Nondialysis Patients Previously Treated with Darbepoetin Alfa. Clinical Journal of the American Society of Nephrology. 8(4). 538–545. 6 indexed citations
12.
Fass, Ronnie, John M. Inadomi, Cong Han, et al.. (2011). Maintenance of Heartburn Relief After Step-Down From Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazole Modified Release. Clinical Gastroenterology and Hepatology. 10(3). 247–253. 51 indexed citations
13.
Fass, Ronnie, et al.. (2011). Maintenance of Heartburn Symptom Relief in Patients Stepped-Down from Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazole MR. The American Journal of Gastroenterology. 106. S5–S6. 1 indexed citations
14.
Metz, David C., Colin W. Howden, María Claudia Pérez, et al.. (2009). Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed‐release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 29(7). 742–754. 57 indexed citations
15.
Metz, David C., Colin W. Howden, María Claudia Pérez, Lois Larsen, & Janet O’Neil. (2008). S1074 Tak-390MR, a Proton Pump Inhibitor with a Novel Dual Delayed Release Formulation, Maintains Healing and Controls Heartburn in GERD Patients with Healed Erosive Esophagitis. Gastroenterology. 134(4). A–171. 3 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio De Rosa Breakdown of academic impact, for papers by Yasusuke Kimoto Breakdown of academic impact, for papers by Lee Breakdown of academic impact, for papers by Seema Varma Breakdown of academic impact, for papers by Óskar Hálfdánarson Breakdown of academic impact, for papers by Steven Caras Breakdown of academic impact, for papers by Jacob Juel Breakdown of academic impact, for papers by K. Huibregtse Breakdown of academic impact, for papers by Toshikazu Otani
Rankless by CCL
2026